Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No changes to the trial details or visible content.
    Difference
    0.1%
    Check dated 2026-03-18T21:25:30.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:33:30.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays 'Results Submitted' and removes the 'No Results Posted' message.
    Difference
    0.1%
    Check dated 2026-03-04T15:23:25.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-status notice and Revision: v3.4.1 were removed; these are administrative and do not affect the study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:19:26.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Notice added at the top of the page informing users about a lapse in government funding and the NIH Clinical Center's operating status, and the page version updated from v3.4.0 to v3.4.1. These updates do not alter the study details, objectives, eligibility, outcomes, or schedules.
    Difference
    0.4%
    Check dated 2026-02-04T10:38:13.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option in the header and updated capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; introduced a new revision note 'Revision: v3.4.0' to reflect the version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.